Through its educational arm, the ISTH Academy, the International Society on Thrombosis and Haemostasis (ISTH) has begun hosting a series of webinars.
This presentation will describe the risk factors, clinical presentation and management of preeclampsia. Emerging prevention and treatment strategies as well as the subsequent maternal health considerations will be highlighted.
Speakers:
Chris Gardiner "Basic pathophysiology of preeclampsia"
Michael Paidas "Clinical aspects"
Moderator:
Rezan Kadir
This meeting is being supported by Instrumetation Labratory
- Basic and clinical scientists in the fields of thrombosis and haemostasis, obstetric haemostasis and pre-eclampsia
- Students, researchers and clinicians interested in obstetric haemostasis
At the conclusion of this activity, I will be able to:
- Detailed understanding of pre-eclampsia as a diverse syndrome and the haemostatic mechanisms involved in its pathogenesis.
- Update knowledge of the mechanisms and importance of disordered haemostasis in pre-eclampsia and the potential therapeutic implications.
Chris Gardiner "Basic pathophysiology of preeclampsia"
Michael Paidas "Clinical aspects"
Name | Company | Role |
Geoffrey Barnes, MD | Portola | Consulting |
Blue Cross Blue Shield of Michigan | Research | |
BMS/Pfizer | Research | |
Chris Ward, PhD | Bayer | Speaker |
Boehringer-Ingelheim | Speaker, Advisory Board | |
BMS/Pfizer | Speaker, Advisory Board | |
Yukio Ozaki | The Sysmex Corporation | Advisory Board |
Michael Paidas | Revo Biologics | PI |
Contact
- 1.00 AMA PRA Category 1 Credit(s)™AMA PRA Category 1 Credit(s)™
- 1.00 Hours of ParticipationHours of Participation credit.